Current issue #42, 2016

20.12.2016

Rigla to rejoin professional association

At the end of the year, Rigla surprised the market when it filed an application for joining the Russian Association of Pharmacy Chains (RAAS). It is worth noticing tha tRigla used to be a RAAS member, then pulled out of this association, after which participated in setting up another association, and finally quit it as well. The fact that Rigla is beingtornbetweendifferentopportunities is indicative of at least two things. Firstly, pharmacyassociationshaveso far failed to come to aformat that would be acceptable for all market players. Secondly, no matter how large apharmacyisit needs a group, with some minor exceptions.

[PharmVestnik # 42, 20/12/2016, p. 1, cont’dp. 5]

Ministry of Industry and Trade to continue assisting Russian pharma in accessing the market

The PharmMedProm (Pharmaceutical and Medical Industry) exhibition traditionally held in December was a progress report of a kind under the Pharma-2010 program. DeputyMinisterof Industry and Trade SergeyTSYB comments on the government program implementation as well as plans for the next year.

[PharmVestnik # 42, 20/12/2016, p.2]

Minpromtorg to continue supporting innovative drug R&D project

The Russian Ministry of Industry and Trade (Minpromtorg) completed the first stage of an innovation promotion program in the Promotion-2016 project office format. Aport folio of the most promising R&D projects was formed that was offered to potentialinve stors within the frameworkof a meeting of the Advisory Board for Foreign Investment in Russia and the 6th Russian-Swedish economic forum “ANewInvestment Potential: Ideas and Opportunities”.

[PharmVestnik # 42, 20/12/2016, p.3]

Lawyers note that sentences for selling unregistered medical devices have been to omildsofar

The news on prosecutinga Samara entrepreneur who had been selling medical device sunregistered in Russia sparked an alarming interest. Lawyers state that...

Для чтения статей необходимо авторизоваться
Вам необходимо войти в свой аккаунт, либо зарегистрировать новый.
Войти

Нет комментариев

Комментариев: 0

Вы не можете оставлять комментарии
Пожалуйста, авторизуйтесь
Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.